Robling Michael, Bekkers Marie-Jet, Bell Kerry, Butler Christopher C, Cannings-John Rebecca, Channon Sue, Martin Belen Corbacho, Gregory John W, Hood Kerry, Kemp Alison, Kenkre Joyce, Montgomery Alan A, Moody Gwenllian, Owen-Jones Eleri, Pickett Kate, Richardson Gerry, Roberts Zoë E S, Ronaldson Sarah, Sanders Julia, Stamuli Eugena, Torgerson David
South East Wales Trials Unit, Centre for Trials Research, Cardiff University, Cardiff, UK.
South East Wales Trials Unit, Centre for Trials Research, Cardiff University, Cardiff, UK.
Lancet. 2016 Jan 9;387(10014):146-55. doi: 10.1016/S0140-6736(15)00392-X. Epub 2015 Oct 22.
Many countries now offer support to teenage mothers to help them to achieve long-term socioeconomic stability and to give a successful start to their children. The Family Nurse Partnership (FNP) is a licensed intensive home-visiting intervention developed in the USA and introduced into practice in England that involves up to 64 structured home visits from early pregnancy until the child's second birthday by specially recruited and trained family nurses. We aimed to assess the effectiveness of giving the programme to teenage first-time mothers on infant and maternal outcomes up to 24 months after birth.
We did a pragmatic, non-blinded, randomised controlled, parallel-group trial in community midwifery settings at 18 partnerships between local authorities and primary and secondary care organisations in England. Eligible participants were nulliparous and aged 19 years or younger, and were recruited at less than 25 weeks' gestation. Field-based researchers randomly allocated mothers (1:1) via remote randomisation (telephone and web) to FNP plus usual care (publicly funded health and social care) or to usual care alone. Allocation was stratified by site and minimised by gestation (<16 weeks vs ≥16 weeks), smoking status (yes vs no), and preferred language of data collection (English vs non-English). Mothers and assessors (local researchers at baseline and 24 months' follow-up) were not masked to group allocation, but telephone interviewers were blinded. Primary endpoints were biomarker-calibrated self-reported tobacco use by the mother at late pregnancy, birthweight of the baby, the proportion of women with a second pregnancy within 24 months post-partum, and emergency attendances and hospital admissions for the child within 24 months post-partum. Analyses were by intention to treat. This trial is registered with ISRCTN, number ISRCTN23019866.
Between June 16, 2009, and July 28, 2010, we screened 3251 women. After enrolment, 823 women were randomly assigned to receive FNP and 822 to usual care. All follow-up data were retrieved by April 25, 2014. 304 (56%) of 547 women assigned to FNP and 306 (56%) of 545 assigned to usual care smoked at late pregnancy (adjusted odds ratio [AOR] 0·90, 97·5% CI 0·64-1·28). Mean birthweight of 742 babies with mothers assigned to FNP was 3217·4 g (SD 618·0), whereas birthweight of 768 babies assigned to usual care was 3197·5 g (SD 581·5; adjusted mean difference 20·75 g, 97·5% CI -47·73 to 89·23. 587 (81%) of 725 assessed children with mothers assigned to FNP and 577 (77%) of 753 assessed children assigned to usual care attended an emergency department or were admitted to hospital at least once before their second birthday (AOR 1·32, 97·5% CI 0·99-1·76). 426 (66%) of 643 assessed women assigned to FNP and 427 (66%) 646 assigned to usual care had a second pregnancy within 2 years (AOR 1·01, 0·77-1·33). At least one serious adverse event (mainly clinical events associated with pregnancy and infancy period) was reported for 310 (38%) of 808 participants (mother-child) in the usual care group and 357 (44%) of 810 in the FNP group, none of which were considered related to the intervention.
Adding FNP to the usually provided health and social care provided no additional short-term benefit to our primary outcomes. Programme continuation is not justified on the basis of available evidence, but could be reconsidered should supportive longer-term evidence emerge.
Department of Health Policy Research Programme.
现在许多国家为青少年母亲提供支持,以帮助她们实现长期的社会经济稳定,并为其子女提供成功的人生开端。家庭护士伙伴关系(FNP)是一项在美国开发并在英国付诸实践的特许强化家访干预措施,由专门招募和培训的家庭护士从怀孕早期到孩子两岁生日进行多达64次结构化家访。我们旨在评估将该计划应用于首次生育的青少年母亲对产后24个月内婴儿和母亲结局的有效性。
我们在英格兰18个地方当局与初级和二级医疗保健组织的合作社区助产机构中进行了一项实用、非盲、随机对照平行组试验。符合条件的参与者为初产妇,年龄在19岁及以下,在妊娠少于25周时招募。现场研究人员通过远程随机化(电话和网络)将母亲(1:1)随机分配至FNP加常规护理(公共资助的健康和社会护理)或仅常规护理组。分配按地点分层,并按妊娠情况(<16周对≥16周)、吸烟状况(是对否)和首选数据收集语言(英语对非英语)进行最小化。母亲和评估人员(基线和24个月随访时的当地研究人员)不设盲,但电话访谈人员设盲。主要终点为母亲在妊娠晚期经生物标志物校准的自我报告烟草使用情况、婴儿出生体重、产后24个月内再次怀孕的妇女比例以及产后24个月内儿童的急诊就诊和住院情况。分析采用意向性分析。本试验已在国际标准随机对照试验编号注册库(ISRCTN)注册,编号为ISRCTN23019866。
在2009年6月16日至2010年7月28日期间,我们筛查了3251名妇女。入组后,823名妇女被随机分配接受FNP,822名接受常规护理。所有随访数据于201年4月25日获取。分配至FNP的547名妇女中有304名(56%)、分配至常规护理的545名妇女中有306名(56%)在妊娠晚期吸烟(调整优势比[AOR]0.90,97.5%置信区间0.64 - 1.28)。分配至FNP的母亲所生742名婴儿的平均出生体重为3217.4克(标准差618.0),而分配至常规护理的768名婴儿的出生体重为3197.5克(标准差581.5;调整平均差异20.75克,97.5%置信区间 - 47.73至89.23)。分配至FNP的母亲所生725名评估儿童中有587名(81%)、分配至常规护理的753名评估儿童中有577名(77%)在两岁生日前至少有一次急诊就诊或住院(AOR 1.32,97.5%置信区间0.99 - 1.76)。分配至FNP的643名评估妇女中有426名(66%)、分配至常规护理的646名妇女中有427名(66%)在两年内再次怀孕(AOR 1.01,0.77 - 1.33)。常规护理组808名参与者(母婴)中有310名(38%)、FNP组810名中有357名(44%)报告了至少一项严重不良事件(主要是与妊娠和婴儿期相关的临床事件),其中无一被认为与干预有关。
在通常提供的健康和社会护理基础上增加FNP对我们的主要结局没有额外的短期益处。基于现有证据,继续实施该计划不合理,但如果出现支持性的长期证据,则可重新考虑。
卫生政策研究计划部。